client logo
Version: 1.0.0 | Published: 8 Oct 2024 | Updated: 269 days ago

Salford Lung Study

Dataset

Documentation

Description:
SLS Asthma - Primary Effectiveness Analysis (PEA) - This population is defined as all ITT subjects (all randomised subjects who receive at least one prescription of study medication [e.g. FF/VI or Usual Care]) who have an ACT total score of < 20 at baseline (Day 0). This population will be based on the treatment to which the subject was randomised. SLS COPD - Primary Effectiveness Analysis (PEA) - This population comprised all ITT subjects (all randomised subjects who received at least one prescription for study medication [e.g. FF/VI or usual care] who had at least one moderate/severe exacerbation in the year prior to Visit 2 (randomisation), as recorded on the eCRF.

Coverage

Spatial:
United Kingdom,England,North West,Salford; United Kingdom,England,North West,Manchester
Typical Age Range:
18-91

Provenance

Origin

Purposes:
Study
Sources:
EPR
Collection Situations:
Other

Temporal

Accrual Periodicity:
Static
Distribution Release Date:
04 December 2016
Start Date:
13 March 2012
End Date:
04 December 2016
Time Lag:
Not applicable

Accessibility

Access

Access Service:
Following receipt of a signed Data Sharing Agreement (DSA), Researchers are provided access to anonymised patient-level data and supporting documentation in a secure data access system, known as the SAS Clinical Trial Data Transparency (CTDT) system.
Delivery Lead Time:
Not applicable
Data Controller:
SHARE (GSK data sharing team)
Data Processor:
GSK Biostatistics (Respiratory)

Usage

Data Use Limitations:
General research use
Resource Creators:
GSK

Format and Standards

Vocabulary Encoding Schemes:
LOCAL
Languages:
en
Formats:
SAS Dataset (.sas7bdat)
We use Cookies
We use tools, such as cookies, to enable essential services and functionality on our site and to collect data on how visitors interact with our site, products and services. By opting in, you agree to our use of these tools for analytics.
Please see our Cookie Policy.